Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement: A Disconnect Between Logic and Data?

Journal of the American College of Cardiology

Volumn 69, Issue 4, 2017, Pages 378-380

  Latib, Azeem ^a,b   Pagnesi, Matteo ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b EMO GVM CENTRO CUORE COLUMBUS   (Italy)

Author keywords

cerebral embolic protection; meta analysis; neuroimaging; stroke; transcatheter aortic valve replacement (TAVR)

Indexed keywords

AORTA STENOSIS; BRAIN DAMAGE; BRAIN EMBOLISM; BRAIN INFARCTION; BRAIN PROTECTION; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; COGNITIVE DEFECT; DEMENTIA; DIFFUSION WEIGHTED IMAGING; EDITORIAL; EMBOLIC PROTECTION DEVICE; HUMAN; IMAGE QUALITY; MEMORY DISORDER; META ANALYSIS (TOPIC); NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATIENT SAFETY; POSTOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; SAMPLE SIZE; SURGICAL RISK; TRANSCATHETER AORTIC VALVE IMPLANTATION; AORTIC VALVE; HEART VALVE PROSTHESIS; LOGIC; SURGERY;

AORTIC VALVE; HEART VALVE PROSTHESIS; HUMANS; INTRACRANIAL EMBOLISM; LOGIC; TRANSCATHETER AORTIC VALVE REPLACEMENT;

EID: 85010469647     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.10.036     Document Type: Editorial

References (9)

1. 1 Leon, M.B., Smith, C.R., Mack, M.J., et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 374 (2016), 1609–1620.
2. 2 Pagnesi, M., Martino, E.A., Chiarito, M., et al. Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: a systematic review and meta-analysis. Int J Cardiol 221 (2016), 97–106.
3. 3 Gress, D.R., The problem with asymptomatic cerebral embolic complications in vascular procedures: what if they are not asymptomatic?. J Am Coll Cardiol 60 (2012), 1614–1616.
4. 4 Van Mieghem, N.M., van Gils, L., Ahmad, H., et al. Filter-based cerebral embolic protection with transcatheter aortic valve implantation: the randomised MISTRAL-C trial. EuroIntervention 12 (2016), 499–507.
5. 5 Haussig, S., Mangner, N., Dwyer, M.G., et al. Effect of a cerebral protection device on brain lesions following transcatheter aortic valve implantation in patients with severe aortic stenosis: the CLEAN-TAVI randomized clinical trial. JAMA 316 (2016), 592–601.
6. TM HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial. Eur Heart J 36 (2015), 2070–2078.
7. 7 Kapadia, S.R., Kodali, S., Makkar, R., et al., on behalf of the SENTINEL Trial Investigators. Protection against cerebral embolism during transcatheter aortic valve replacement. J Am Coll Cardiol 69 (2017), 367–377.
8. 8 Rodés-Cabau, J., Kahlert, P., Neumann, F.J., et al. Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot study. J Am Coll Cardiol Intv 7 (2014), 1146–1155.
9. 9 Insel, T.R., Landis, S.C., Collins, F.S., Research priorities. The NIH BRAIN Initiative. Science 340 (2013), 687–688.